DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
A••• P••••••••• I••
Drug Discovery & Developmentgroup grade Aoff every schedule since Dec 31, 2022sponsor unattributed
Also written as: Equity
Nothing material in the last 200 days. No dated change on record yet.
Principal held
at least $40.0M
sum of BDC pieces, a lower bound
Fair value
$46.0M
104c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
1 equity pieces beside them
Next maturity
Sep 1, 2024
$40.0M inside 24 months
On the tape since
Dec 31, 2022
latest Dec 31, 2022
Events
1
dated, non-routine
Lender marks
each lender's own fair value over cost at Dec 31, 2022, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| H••••••• C••••••• I••• | $40M | 104¢ | new this quarter |
Every BDC piece · 2 positions across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| H••••••• C••••••• I••• | term loan first lien S••••• S••••••, M••••••• D••• S•••••••• 2024, P•••• + 6.40%, F•••• rate 9.65%, Cap rate 15 | $40.0M | $43.2M 104c | S+640 bp |
| H••••••• C••••••• I••• | equity equity A••••••••• D••• 7/31/2011, Series C••••• S•••• | Not disclosed | $2.8M 166c |
Capital structure as the BDCs see it
latest quarter end Dec 31, 2022
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Dec 31, 2022 | at least $40.0M | 104c | S+640 bp | Sep 1, 2024 | 1 |
Equity pieces beside the debt: equity ($2.8M fair value, 1 BDC)
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Dec 31, 2022 | 1 | $40.0M | $43.2M | 104c | 0 |
What changed
- Facility left every BDC scheduleDec 31, 2022
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- A••• P•••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Drug Discovery & Developmentreportedas one filer wrote it